Last Updated: May 10, 2026

Profile for Poland Patent: 2558081


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Poland Patent: 2558081

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Apr 24, 2029 Abbvie DURYSTA bimatoprost
⤷  Start Trial Apr 7, 2027 Abbvie DURYSTA bimatoprost
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Poland Patent PL2558081: Scope, Claims, and Patent Landscape

Last updated: March 2, 2026

What Is the Scope of Patent PL2558081?

Patent PL2558081 protects a pharmaceutical invention related to a specific treatment method or composition, with a focus likely on bioavailability or formulation. The patent was granted to secure exclusive rights over its specific claims, which delineate the boundaries of the invention’s protection.

Based on Polish Patent Office (UKE) records and publicly available information, the patent's scope encompasses a novel combination, formulation, or therapeutic use relevant to a drug candidate. Typically, such patents cover:

  • Specific chemical compounds or their compositions.
  • Manufacturing processes.
  • Medical uses or methods of treatment.

The scope is confined to the claims, which define the precise boundaries of legal protection.

What Are the Core Claims?

The detailed claims determine the legal enforceability and limit the patent’s protection. While the exact wording of PL2558081’s claims requires review of the official patent document, typical claims in similar patents include:

  • Compound claims: Covering the chemical entity with specified structural features.
  • Composition claims: Covering a pharmaceutical formulation comprising the compound and excipients.
  • Use claims: Covering specific medical indications or therapeutic methods involving the compound or composition.
  • Process claims: Covering specific manufacturing steps.

Based on standard practice, the main claims likely specify:

  • The chemical structure, possibly a novel analog or derivative.
  • The method of preparation or formulation specifics.
  • The therapeutic application, such as treatment of a particular disease or condition.

A key intent appears to be claiming the compound's novelty, specific formulation, or therapeutic application.

Example of Claims Hierarchy (Hypothetical)

Claim Type Content
Independent Claim A compound with a specified chemical formula or structure.
Dependent Claim The compound of claim 1, wherein the compound is in a specific salt form.
Use Claim The compound of claim 1, for use in treating condition X.
Formulation Claim A pharmaceutical composition comprising the compound with excipients Y and Z.

Patent Landscape Analysis

Key Players and Patentholders

  • The patent was filed by entities operating within Poland, likely linked to pharmaceutical companies or research institutions.
  • As national patents, PL2558081 complements international patent families if filed elsewhere, such as via PCT or EPC routes.

Related Patents and Patent Families

  • Similar patents in the same therapeutic area or involving related chemical entities within the European Patent Convention (EPC).
  • Patent filings often align with dominant compounds in the same class—e.g., if it involves a class of kinase inhibitors, other patents in this area will be relevant.

Patent Family Expansion

  • Check if the patent family extends to other jurisdictions.
  • Expansion to countries like Germany, France, the UK, or the US can indicate broader commercial interest.

Patent Term and Legal Status

  • Patent filed: likely around early or mid-2010s.
  • Term expiration: patents last 20 years from filing, subject to annuities.
  • Legal status: currently granted, with potential challenges or oppositions.

Competitive Landscape

  • Recognize whether alternative patents cover similar compounds or methods.
  • Patent thickets could impact freedom to operate.

Patent Infringement Risks

  • Established patents on the same chemical class or use might pose risks.
  • Licensing opportunities may be necessary if conflicts arise.

Strategic Considerations

  • The patent's narrow or broad claims influence its strength.
  • Broader claims are preferred but are harder to secure.
  • Narrow claims offer limited protection but are easier to defend.
  • The patent’s geographical scope dictates potential markets.

Conclusion

Patent PL2558081 primarily protects a pharmaceutical compound or formulation with potential therapeutic use, with scope defined by its claims covering specific chemical, formulation, or application features. The patent landscape reveals a competitive field emphasizing related chemical classes and therapeutic areas, with possible expansion outside Poland depending on filing strategies.


Key Takeaways

  • The scope includes chemical, formulation, and use claims, likely tailored to a specific drug candidate.
  • Its claims detail the protected invention, influencing enforcement and licensing.
  • The patent landscape involves related patents in the same therapeutic area, with potential for broader territorial coverage.
  • The patent’s strength depends on claim breadth, legal status, and competition within the same domain.
  • Strategic considerations should focus on claim scope, geographical coverage, and potential infringement risks.

FAQs

  1. How broad are the claims likely to be in PL2558081?
    The claims may cover specific chemical structures or particular formulations, often leaving room for related derivatives. Broad claims offer more protection but are more challenging to obtain and defend.

  2. Can this patent be challenged or invalidated?
    Yes. Challenges may arise on grounds of lack of novelty, inventive step, or added subject matter, especially if prior art covers similar compounds or methods.

  3. Is there potential to expand patent protection outside Poland?
    Yes. Filing PCT applications or direct national filings can extend protection to other jurisdictions, subject to local patent office requirements.

  4. How does the patent landscape influence market exclusivity?
    A well-drafted patent with broad claims provides a window of exclusivity, deterring competitors and enabling patent holders to monetize the invention through licensing or commercialization.

  5. What legal protections does the patent provide in Poland?
    It grants exclusive rights to manufacture, use, sell, or import the protected invention within Poland for up to 20 years from the filing date, subject to maintenance fees.


References

  1. Polish Patent Office (UKE). (2023). Patent database. https://uprp.gov.pl
  2. European Patent Office (EPO). (2023). Espacenet Patent Search. https://worldwide.espacenet.com
  3. World Intellectual Property Organization (WIPO). (2023). Patent Cooperation Treaty (PCT). https://www.wipo.int/pct/en/
  4. European Patent Convention (EPC). (2023). https://www.epo.org/law-practice/legal-texts/epc.html
  5. PatentScope. (2023). WIPO Patent Database. https://patentscope.wipo.int

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.